newsfilter
← Latest News
Business Wire·

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (NASDAQ:INVA), today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, Allschwil